172 related articles for article (PubMed ID: 19549416)
1. [Dendritic cell-based immunotherapy for multiple myeloma -- review].
Zhu XJ; He L; Sun XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):821-5. PubMed ID: 19549416
[TBL] [Abstract][Full Text] [Related]
2. DC in multiple myeloma immunotherapy.
Turtle CJ; Brown RD; Joshua DE; Hart DN
Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989
[TBL] [Abstract][Full Text] [Related]
3. Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
Röllig C; Schmidt C; Bornhäuser M; Ehninger G; Schmitz M; Auffermann-Gretzinger S
J Immunother; 2011 Jan; 34(1):100-6. PubMed ID: 21150718
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell vaccines in the treatment of multiple myeloma: advances and limitations.
Büchler T; Hajek R
Med Oncol; 2002; 19(4):213-8. PubMed ID: 12512914
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-based immunotherapy for the treatment of hematological malignancies.
Büchler T; Michalek J; Kovarova L; Musilova R; Hajek R
Hematology; 2003 Apr; 8(2):97-104. PubMed ID: 12745659
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based immunotherapy in multiple myeloma.
Yi Q
Leuk Lymphoma; 2003 Dec; 44(12):2031-8. PubMed ID: 14959845
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in multiple myeloma: current strategies and future prospects.
Yi Q
Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of hematological malignancies using dendritic cells.
Van de Velde AL; Berneman ZN; Van Tendeloo VF
Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.
Hájek R; Butch AW
Med Oncol; 2000 Feb; 17(1):2-15. PubMed ID: 10713654
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy using dendritic cells against multiple myeloma: how to improve?
Nguyen-Pham TN; Lee YK; Kim HJ; Lee JJ
Clin Dev Immunol; 2012; 2012():397648. PubMed ID: 22481968
[TBL] [Abstract][Full Text] [Related]
11. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
Rhee Fv
Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
[No Abstract] [Full Text] [Related]
12. Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma.
Wang S; Hong S; Wezeman M; Qian J; Yang J; Yi Q
Front Biosci; 2007 May; 12():3566-75. PubMed ID: 17485322
[TBL] [Abstract][Full Text] [Related]
13. Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
Verheye E; Bravo Melgar J; Deschoemaeker S; Raes G; Maes A; De Bruyne E; Menu E; Vanderkerken K; Laoui D; De Veirman K
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055096
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-based treatment of cancer: closing in on a cellular therapy.
Valone FH; Small E; MacKenzie M; Burch P; Lacy M; Peshwa MV; Laus R
Cancer J; 2001; 7 Suppl 2():S53-61. PubMed ID: 11777265
[TBL] [Abstract][Full Text] [Related]
16. RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells.
Tyagi RK; Mangal S; Garg N; Sharma PK
Expert Rev Anticancer Ther; 2009 Jan; 9(1):97-114. PubMed ID: 19105710
[TBL] [Abstract][Full Text] [Related]
17. Optimizing dendritic cell-based immunotherapy for cancer.
Zhong H; Shurin MR; Han B
Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell vaccines for cancer treatment.
Gabrilovich DI
Curr Opin Mol Ther; 2002 Oct; 4(5):452-8. PubMed ID: 12435046
[TBL] [Abstract][Full Text] [Related]
19. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
20. DC-based immunotherapy of B-cell malignancies.
Reichardt VL; Brossart P
Cytotherapy; 2004; 6(1):62-7. PubMed ID: 14985168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
